Jun 18, 2020 07:00 PM IST
The rally in the equity market helped the market capitalisation of BSE-listed companies gain Rs 1,91,540.25 crore to Rs 1,35,48,847.54 crore.
- Jun 16, 2020 01:15 PM IST
The company has received the final approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Deferasirox tablets in the strength of 180 mg, Alembic Pharmaceuticals said in a BSE filing.
- Jun 16, 2020 11:20 AM IST
The approval by the US Food and Drug Administration (USFDA) for Deferasirox tablets is for multiple strengths of 90 mg, 180 mg and 360 mg, Cadila Healthcare said in a regulatory filing.
- Jun 14, 2020 08:38 AM IST
While FIIs sold equities worth Rs 1,731.81 crore, DIIs sold equities worth of Rs 400.06 crore in the week that ended on June 12.
- Jun 05, 2020 01:08 PM IST
The company has received final approval from the US Food and Drug Administration (USFDA) to market Atazanavir capsules in strengths of 150 mg, 200 mg and 300 mg, Zydus Cadila said in a statement.
- Jun 02, 2020 03:15 PM IST
The approval was granted during the board meeting held on Monday, Hindustan Copper said in a filing to BSE.
- Jun 02, 2020 12:20 PM IST
The approval is granted to the company's step-down wholly owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.
- Jun 01, 2020 03:45 PM IST
The board of directors in its meeting on Monday considered and approved a fundraising of up to Rs 3,500 crore through rights issue, Mahindra Finance said in a regulatory filing.
- Jun 01, 2020 11:57 AM IST
"The financial recourse and management committee of the board of directors of the company held on June 1...has approved the allotment of 5,000 secured redeemable non-convertible debentures ...aggregating to Rs 5,00,00,00,000,... on a private placement basis to be listed on the BSE," Manappuram Finance said in a regulatory filing.
- May 27, 2020 01:24 PM IST
“The Board has also authorised the Committee of Directors to decide on matters and transactions relating to aforesaid proposed issuance and allotment of NCDs including but not limited to finalisation and approval of terms and conditions of issue, number of NCDs and timing of the issue from time to time,” the filing said.
- May 27, 2020 10:59 AM IST
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in strength of 375 mg and 750 mg, the drug maker said in a statement.
- May 26, 2020 04:50 PM IST
Besides, the exchange is planning to provide e-KYC services to stock brokers and other approved intermediaries in the near future, BSE said in a statement.
- May 25, 2020 09:21 PM IST
Motilal Oswal is bullish on BSE has recommended buy rating on the stock with a target price of Rs 630 in its research report dated May 21, 2020.
- May 21, 2020 10:30 PM IST
Total income dropped to Rs 155.79 crore in the fourth quarter ended March 31, 2020, from Rs 182.08 crore in the same period preceding fiscal.
- May 21, 2020 12:45 PM IST
"3,000 Non-Convertible Debentures of face value of Rs 10 lakh each aggregating to Rs 300 crore have been allotted today, on a private placement basis, to ICICI Bank Ltd," according to a regulatory filing.
- May 21, 2020 09:48 AM IST
"It has received final approval for its Abbreviated New Drug Application (ANDA) for Dihydroergotamine Mesylate nasal spray 4mg/mL from the United States Food and Drug Administration (USFDA) with a competitive generic therapy (CGT) designation," the company said in a filing to BSE.
- May 20, 2020 01:48 PM IST
"An issue of 3,000 NCDs having a face value of Rs 10 lakh each for cash at par aggregating to Rs 300 crore, on a private placement basis has been approved today," the company said in a BSE filing.
- May 20, 2020 01:40 PM IST
"The Committee of Directors has today approved allotment of 10,000 –- 8.25 per cent unsecured, rated, listed, redeemable, NCDs of face value Rs 10,00,000 each, for cash aggregating to Rs 1,000 crore, to identified investor on private placement basis," Tata Steel said in a filing to BSE.
- May 18, 2020 04:13 PM IST
As per the release, the revised listing fee structure will be applicable for the existing companies as well as for all the firms awaiting to be listed on BSE.
- May 17, 2020 01:49 PM IST
RIL's market cap plunged Rs 65,232.46 crore to Rs 9,24,855.56 crore.
- May 10, 2020 10:33 AM IST
In the top-10 list, only Reliance Industries Ltd and Bharti Airtel managed to close the trading week with gains.
- May 08, 2020 01:11 PM IST
The company has received the EIR from the US Food and Drug Administration (USFDA) for the pre-approval and good manufacturing practice inspection of its small molecules active pharmaceutical ingredient (API) manufacturing facility at Biocon Park SEZ, Bengaluru, it said in a filing to BSE.
- May 08, 2020 12:05 PM IST
The US Food and Drug Administration (USFDA) had issued a warning letter to the facility in November, 2015, after inspecting it in 2014.
- May 07, 2020 09:17 AM IST
Despite the sharp run-up, analysts feel that the scrip still has some steam left.
- May 05, 2020 08:15 PM IST
The BSE benchmark ended at 31,453.51, down 261.84 points or 0.83 percent on Tuesday.